Skip Navigation



Brain Advance Access published online on June 24, 2009

Brain, doi:10.1093/brain/awp151
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
132/10/e127    most recent
awp151v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Voon, V.
Right arrow Articles by Moro, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voon, V.
Right arrow Articles by Moro, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2009). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Parkinson's disease, DBS and suicide: a role for serotonin?

Valerie Voon1,2, Paul Krack3, Anthony E. Lang2, Andres M. Lozano2, Kathy Dujardin4, Michael Schüpbach5, Stephane Thobois6, Filippo Tamma7, Jan Herzog8, Johan Samanta9, Cynthia Kubu10, Helene Rossignol3, Yu-Yan Poon2, Jean A. Saint-Cyr2, Claire Ardouin3 and Elena Moro2

 1 National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA  2 Division of Neurology, Department of Medicine, University of Toronto, UHN, Toronto, Canada  3 Department of Neurology, University Joseph Fourier, Grenoble, France  4 Clinique Neurologique, Lille University Hospital, Lille, France  5 National Institute of Health and Medical Research (INSERM), Hôpital de la Pitié-Salpêtrière, Paris, France  6 Department of Neurology, Université Lyon I, Hospital Neurologique Pierre Wertheimer, Lyon, France  7 Department of Neurology, University of Milan, Italy  8 Department of Neurology, Christian-Albrechts-Universität Kiel, Kiel, Germany  9 Academic Medical Center of Amsterdam, Amsterdam, The Netherlands 10 Department of Psychiatry and Psychology, University of Arizona, Phoenix, AZ, USA 11 The Cleveland Clinic Foundation, OH, USA

Correspondence to: Dr Valerie Voon, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10, Room 5S213, Bethesda, MD 20892-1428, USA E-mail: voonv@ninds.nih.gov

Received May 7, 2009. Accepted May 7, 2009.

The first 10% of the full text of this article appears below.

We would like to thank Temel et al. for their communication highlighting the potential role of serotonin and suicidal behaviours, which are intriguing and potentially of relevance. Temel et al. have previously shown that subthalamic nucleus (STN) HFS in a rat study inhibits serotonergic dorsal raphe firing rate and elicits depressive-like behaviour which can be prevented with pre-treatment with a serotonin reuptake inhibitor (Temel et al., 2007Go). Post-mortem and biological challenge studies suggest serotonergic hyporesponsivity particularly in suicide attempts of high lethality and lower prefrontal serotonin receptor density with a compensatory increase in midbrain serotonin neuron density and function (Mann et al., 1996Go; Oquendo et al., 2003Go; Boldrini et al., 2008Go).

Temel et al. point to . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?